169 related articles for article (PubMed ID: 22300294)
1. Loxapine P-glycoprotein interactions in vitro.
Reed A; Huie K; Perloff ES; Cassella JV; Takahashi LH
Drug Metab Lett; 2012 Mar; 6(1):26-32. PubMed ID: 22300294
[TBL] [Abstract][Full Text] [Related]
2. A Low Dose of Aripiprazole Has the Strongest Sensitization Effect Among 19 Repositioned Bipolar Drugs in P-gp-overexpressing Drug-resistant Cancer Cells.
Jiang C; Lee SH; Park JH; Lee JS; Park JW; Kim JR; Lee SH; Kim HS; Yoon S
Anticancer Res; 2021 Feb; 41(2):687-697. PubMed ID: 33517273
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein.
Wang JS; Zhu HJ; Markowitz JS; Donovan JL; DeVane CL
Psychopharmacology (Berl); 2006 Sep; 187(4):415-23. PubMed ID: 16810505
[TBL] [Abstract][Full Text] [Related]
4. In vitro P-glycoprotein affinity for atypical and conventional antipsychotics.
Boulton DW; DeVane CL; Liston HL; Markowitz JS
Life Sci; 2002 May; 71(2):163-9. PubMed ID: 12031686
[TBL] [Abstract][Full Text] [Related]
5. Validation and application of Caco-2 assays for the in vitro evaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissions.
Elsby R; Surry DD; Smith VN; Gray AJ
Xenobiotica; 2008 Jul; 38(7-8):1140-64. PubMed ID: 18668443
[TBL] [Abstract][Full Text] [Related]
6. Transport characteristics of tryptanthrin and its inhibitory effect on P-gp and MRP2 in Caco-2 cells.
Zhu X; Zhang X; Ma G; Yan J; Wang H; Yang Q
J Pharm Pharm Sci; 2011; 14(3):325-35. PubMed ID: 21824448
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of P-glycoprotein-mediated efflux of digoxin and its metabolites by macrolide antibiotics.
Hughes J; Crowe A
J Pharmacol Sci; 2010; 113(4):315-24. PubMed ID: 20724802
[TBL] [Abstract][Full Text] [Related]
8. Derivation of a System-Independent
Chaudhry A; Chung G; Lynn A; Yalvigi A; Brown C; Ellens H; O'Connor M; Lee C; Bentz J
Drug Metab Dispos; 2018 Mar; 46(3):279-290. PubMed ID: 29317410
[TBL] [Abstract][Full Text] [Related]
9. Effects of Fostamatinib on the Pharmacokinetics of Digoxin (a P-Glycoprotein Substrate): Results From in Vitro and Phase I Clinical Studies.
Martin P; Gillen M; Millson D; Oliver S; Brealey C; Elsby R; Baluom M; Lau D; Mant T
Clin Ther; 2015 Dec; 37(12):2811-22. PubMed ID: 26514315
[TBL] [Abstract][Full Text] [Related]
10. Dabigatran Etexilate and Digoxin: Comparison as Clinical Probe Substrates for Evaluation of P-gp Inhibition.
Chu X; Galetin A; Zamek-Gliszczynski MJ; Zhang L; Tweedie DJ;
Clin Pharmacol Ther; 2018 Nov; 104(5):788-792. PubMed ID: 30238965
[No Abstract] [Full Text] [Related]
11. Effect of the flavonoids biochanin A and silymarin on the P-glycoprotein-mediated transport of digoxin and vinblastine in human intestinal Caco-2 cells.
Zhang S; Morris ME
Pharm Res; 2003 Aug; 20(8):1184-91. PubMed ID: 12948016
[TBL] [Abstract][Full Text] [Related]
12. Induction of human P-glycoprotein in Caco-2 cells: development of a highly sensitive assay system for P-glycoprotein-mediated drug transport.
Shirasaka Y; Kawasaki M; Sakane T; Omatsu H; Moriya Y; Nakamura T; Sakaeda T; Okumura K; Langguth P; Yamashita S
Drug Metab Pharmacokinet; 2006 Oct; 21(5):414-23. PubMed ID: 17072095
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in silico evaluation of P-glycoprotein inhibition through
Hosseini Balef SS; Piramoon M; Hosseinimehr SJ; Irannejad H
Chem Biol Drug Des; 2019 Mar; 93(3):283-289. PubMed ID: 30270513
[TBL] [Abstract][Full Text] [Related]
14. Relationship between P-glycoprotein and second-generation antipsychotics.
Moons T; de Roo M; Claes S; Dom G
Pharmacogenomics; 2011 Aug; 12(8):1193-211. PubMed ID: 21843066
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory effects of mitragynine on P-glycoprotein in vitro.
Rusli N; Amanah A; Kaur G; Adenan MI; Sulaiman SF; Wahab HA; Tan ML
Naunyn Schmiedebergs Arch Pharmacol; 2019 Apr; 392(4):481-496. PubMed ID: 30604191
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of human cytochrome P450 3A4 by N-[2(R)-hydroxy-1(S)-indanyl]-5-[2(S)-(1, 1-dimethylethylaminocarbonyl)-4-[(furo[2, 3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethy lpentanamide and P-glycoprotein by valspodar in gene transfectant systems.
Kawahara I; Kato Y; Suzuki H; Achira M; Ito K; Crespi CL; Sugiyama Y
Drug Metab Dispos; 2000 Oct; 28(10):1238-43. PubMed ID: 10997946
[TBL] [Abstract][Full Text] [Related]
17. Discriminative stimulus properties in rats of the novel antipsychotic quetiapine.
Smith JA; Goudie AJ
Exp Clin Psychopharmacol; 2002 Nov; 10(4):376-84. PubMed ID: 12498334
[TBL] [Abstract][Full Text] [Related]
18. Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats.
Zhang H; Yao M; Morrison RA; Chong S
Arch Pharm Res; 2003 Sep; 26(9):768-72. PubMed ID: 14560928
[TBL] [Abstract][Full Text] [Related]
19. The relevance of assessment of intestinal P-gp inhibition using digoxin as an in vivo probe substrate.
Shi JG; Zhang Y; Yeleswaram S
Nat Rev Drug Discov; 2011 Jan; 10(1):75; author reply 75. PubMed ID: 21193869
[No Abstract] [Full Text] [Related]
20. Gastrointestinal absorption of pimozide is enhanced by inhibition of P-glycoprotein.
Morishita H; Okawa K; Ishii M; Mizoi K; Ito MA; Arakawa H; Yano K; Ogihara T
PLoS One; 2020; 15(10):e0232438. PubMed ID: 33119612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
